We are live on ! Find out more
EXOZ

eXoZymes Inc

7 hedge funds and large institutions have $472K invested in eXoZymes Inc in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

0% more funds holding

Funds holding: 7 → 7 (0)

0% more ownership

Funds ownership: 0.75% → 0.75% (+0%)

31% less capital invested

Capital invested by funds: $682K → $472K (-$211K)

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

EXOZ Hedge Fund Activity: Q1 2026 in Review

7 of the 8,206 institutional investors tracked by Wall St. Rank reported a position in eXoZymes Inc (EXOZ) for Q1 2026, worth a combined $472K — down 31% from $682K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new EXOZ positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $12K. The largest seller was Geode Capital Management, cutting an estimated $15.3K.

  • 7 institutional investors held eXoZymes Inc (EXOZ) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $472K of eXoZymes Inc stock for Q1 2026, down 31% quarter-over-quarter.
  • 2 funds opened new eXoZymes Inc positions in Q1 2026 and 1 closed out, a net change of +1 holder.
  • The largest eXoZymes Inc buyer in Q1 2026 was Tower Research Capital (TRC), an estimated $12K added.
  • The largest eXoZymes Inc seller in Q1 2026 was Geode Capital Management, an estimated $15.3K sold.

Based on aggregated 13F filings for Q1 2026.